NPNico H J Pijls

Nico H J Pijls

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nico H J Pijls has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Percutaneous coronary intervention or bypass surgery in multivessel disease? A tailored approach based on coronary pressure measurement

    by Kees‐Joost Botman, Nico H.J. Pijls, Jan Willem Bech, Wilbert Aarnoudse, Kathinka Peels, Bart van Straten, Olaf Penn, H. Rolf Michels, Hans Bonnier, Jacques J. Koolen

    The optimal revascularization strategy, percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG), for patients with multivessel coronary artery disease (MVD) remains controversial. The aim of the present study was to compare the long‐term outcomes after selective PCI of only hemodynamically significant lesions (fractional flow reserve, or FFR < 0.75) to CABG of all stenoses in patients with MVD. In 150 patients with MVD referred for CABG, FFR was determined in 381 coronary arteries considered for bypass grafting. If the FFR was less than 0.75 in three vessels or in two vessels including the proximal left anterior descending (LAD) artery, CABG was performed (CABG group). If only one or two vessels were physiologically significant (not including the proximal LAD), PCI of those lesions was performed (PCI group). Of the 150 patients, 87 fulfilled the criteria for CABG and 63 for PCI. There were no significant differences in the angiographic or other baseline characteristics between the two groups. At 2‐year follow‐up, no differences were seen in adverse events, including repeat revascularization (event‐free survival 74% in the CABG group and 72% in the PCI group). A similar number of patients were free from angina (84% in the CABG group and 82% in the PCI group). Importantly, the results in both groups were as good as the surgical groups in previous studies comparing PCI and CABG in MVD. In patients with multivessel disease, PCI in those with one or two hemodynamically significant lesions as identified by an FFR < 0.75 yields a similar favorable outcome as CABG in those with three or more culprit lesions despite a similar angiographic extent of disease. Catheter Cardiovasc Interv 2004;63:184–191.


  • Open Access

    Optimum guidance of complex PCI by coronary pressure measurement

    by Nico H J Pijls

    While this decrease in the reintervention rate is not small, it is not that large either. It means that the re-intervention rate today is in the range of 20% if a completely unselected “true life” patient population is considered. And it is beyond doubt that the interventional community has eagerly waited for further developments to decrease this 20% reintervention rate.


  • Randomized study to compare balloon angioplasty and elective stent implantation in venous bypass grafts: The Venestent Study

    by Clara E.E. Hanekamp, Jacques J. Koolen, Peter Den Heijer, Martin J. Schalij, Jan J. Piek, Frits W.H.M. Bär, Iwan De Scheerder, Hans J.R.M. Bonnier, Nico H.J. Pijls

    The aim of the study was to compare acute and long‐term angiographic and clinical outcome of balloon angioplasty and elective stenting in de novo lesions in the body of a saphenous vein graft (SVG). A total of 150 patients, with de novo lesions in SVG, were randomly assigned to balloon angioplasty or elective Wiktor I stent implantation. The angiographic restenosis rate at 6‐month follow‐up was 32.8% in the balloon group and 19.1% in the stent group (P = 0.069). At 1‐year follow‐up, target vessel revascularization rate was 31.4% vs. 14.5% (P < 0.05), and event‐free survival was 60.0% vs. 76.3% (P < 0.05) for the balloon and stent group, respectively. Elective stent implantation in de novo SVG lesions is associated with a significant lower target vessel revascularization rate and a significant higher event‐free survival at 1‐year follow‐up as compared to balloon angioplasty. Catheter Cardiovasc Interv 2003;60:452–457.


  • Coronary Pressure Measurement After Stenting Predicts Adverse Events at Follow-Up

    by Nico H.J. Pijls, Volker Klauss, Uwe Siebert, Eric Powers, Kenji Takazawa, William F. Fearon, Javier Escaned, Yukio Tsurumi, Takashi Akasaka, Habib Samady, et al.

    Background — Coronary stenting is associated with a restenosis rate of 15% to 20% at 6-month follow-up, despite optimum angiographic stent implantation. In this multicenter registry, we investigated the relation between optimum physiological stent implantation as assessed by poststent fractional flow reserve (FFR) and outcome at 6 months. Methods and Results — In 750 patients, coronary pressure measurement at maximum hyperemia was performed after angiographically apparently satisfactory stent implantation. Poststenting FFR was calculated and related to major adverse events (including need for repeat target vessel revascularization) at 6 months. In 76 patients (10.2%), at least 1 adverse event occurred. Five patients died, 19 experienced myocardial infarction, and 52 underwent at least 1 repeat target vessel revascularization. By multivariate analysis, FFR immediately after stenting was the most significant independent variable related to all types of events. In 36% of the patients, FFR normalized (>0.95), and event rate was 4.9% in that group. In 32% of the patients, poststent FFR was between 0.90 and 0.95, and event rate was 6.2%. In 32% of patients, poststent FFR was P Conclusions — FFR after stenting is a strong independent predictor of outcome at 6 months.